INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: BYR-194519 |   Service

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Induced Pluripotent Stem Cell (iPS Cell) Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET

7.1 GLOBAL INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA INDUCED PLURIPOTENT STEM CELL (IPS CELL) MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Axol Bioscience Ltd

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Cynata Therapeutics Limited

16.3 Evotec SE

16.4 Fate Therapeutics, Inc

16.5 FUJIFILM Cellular Dynamics, Inc

16.6 Ncardia

16.7 Pluricell Biotech

16.8 REPROCELL USA, Inc

16.9 Sumitomo Dainippon Pharma Co, Ltd

16.10 Takara Bio, Inc

16.11 Thermo Fisher Scientific, Inc

16.12 ViaCyte, Inc

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Type
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Others

By Application
Academic Research
Drug Development And Discovery
Toxicity Screening
Regenerative Medicine

Companies

Axol Bioscience Ltd
Cynata Therapeutics Limited
Evotec SE
Fate Therapeutics, Inc
FUJIFILM Cellular Dynamics, Inc
Ncardia
Pluricell Biotech
REPROCELL USA, Inc
Sumitomo Dainippon Pharma Co, Ltd
Takara Bio, Inc
Thermo Fisher Scientific, Inc
ViaCyte, Inc

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.